Sort
11,323 grants matching “glioblastoma”
Central Nervous System Drug Delivery Techniques
$197,254John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
MARIMASTAT IN PATIENTS W/ GLIOBLASTOMA MULTIFORME OF GLIOSARCOMA
$197,196University Of Michigan At Ann Arbor · M01 · FY2002 · RR
Biomimetic Hydrogel Niches to Study the Malignant Phenotype of Glioblastoma Multiforme
$197,173Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2019 · CA
Synthetic Lethal Combination of KRP203/Fingolimod with PI3K signaling for glioblastoma multiforme death by catastrophic vacuolization
$197,104Atsuo Sasaki · University Of Cincinnati · R21 · FY2017 · NS
Development of A Novel Imaging Strategy for Evaluation of CAR T-Cell Therapy in Glioblastoma
$197,036Corinne Beinat · Stanford University · R21 · FY2022 · NS
Genomics & Bioinformatics
$196,990Cameron Brennan · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Irreversible electroporation for combinatorial GBM treatment
$196,981Rafael Vidal Davalos · Wake Forest University Health Sciences · P01 · FY2021 · CA
Molecular Imaging of Pyruvate Kinase M2
$196,909Corinne Beinat · Stanford University · R21 · FY2024 · EB
Oncolytic HSV Cancer Therapy: Enhancement by Vasculostatin Gene Therapy
$196,875Balveen Kaur · Ohio State University · R21 · FY2007 · NS
Chronotherapy for glioblastoma
$196,875Erik Herzog · Washington University · R21 · FY2022 · NS
Molecular Imaging of Pyruvate Kinase M2
$196,873Corinne Beinat · Stanford University · R21 · FY2023 · EB
Investigation of Sirt1 activation to target IDH mutant glioma
$196,802Julie Joann Miller · Massachusetts General Hospital · K08 · FY2025 · NS
Investigation of Sirt1 activation to target IDH mutant glioma
$196,802Julie Joann Miller · Massachusetts General Hospital · K08 · FY2023 · NS
Investigation of Sirt1 activation to target IDH mutant glioma
$196,802Julie Joann Miller · Massachusetts General Hospital · K08 · FY2024 · NS
Instrument for Intracerebral Microinjections and Electrophysiology
$196,483Lee D Margolin · Fhc, Inc. · R44 · FY2008 · NS
MOUSE MODEL CORE
$196,460David E Housman · Massachusetts Institute Of Technology · U54 · FY2009 · CA
Clinical Trials and Imaging Core
$196,430Annick Desjardins · Duke University · P01 · FY2019 · CA
Triple Anti-Angiogenic Therapy for Brain Tumors
$196,313W K Alfred Yung · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Pre-clinical Translation of Regulatory T-cell Inhibition in Brain Tumors
$196,250John H Sampson · Duke University · R21 · FY2011 · NS
Concurrent Immune Stimulation and Inhibition of Angiogenesis for Glioma Therapy
$196,219John R Ohlfest · University Of Minnesota · R21 · FY2007 · NS
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
$196,205Michael E. Berens · Beckman Research Institute/City Of Hope · U19 · FY2023 · CA
Small molecule inhibitors with a therapeutic window for EGFR signaling variants in glioblastoma
$196,169Michael J Eck · Brigham And Women'S Hospital · U19 · FY2021 · CA
Target migratory nature of glioblastoma stem cells
$196,152Cho-Lea Tso · University Of California Los Angeles · R21 · FY2009 · CA
TERT transcriptional deregulation in thyroid cancer progression
$196,150Inigo Landa-Lopez · Brigham And Women'S Hospital · K22 · FY2020 · CA
Animal Core (Core D)
$196,147Betty Kim · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA